S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Late-night shows return after writers strike as actors resume talks that could end their standoff
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Late-night shows return after writers strike as actors resume talks that could end their standoff
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Late-night shows return after writers strike as actors resume talks that could end their standoff
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Federal student loan payments are starting again. Here's what you need to know
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video) (Ad)
Bank of Japan survey shows manufacturers optimistic about economy
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
Laser breakthrough could send stock soaring 2,467% (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Better Than Oil Stocks (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Late-night shows return after writers strike as actors resume talks that could end their standoff
NASDAQ:ALXO

ALX Oncology (ALXO) Stock Forecast, Price & News

$4.80
-0.15 (-3.03%)
(As of 09/29/2023 08:52 PM ET)
Compare
Today's Range
$4.71
$4.99
50-Day Range
$4.19
$6.16
52-Week Range
$3.94
$13.64
Volume
133,500 shs
Average Volume
228,526 shs
Market Capitalization
$197.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.00

ALX Oncology MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
337.5% Upside
$21.00 Price Target
Short Interest
Bearish
16.47% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of ALX Oncology in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$47,889 Sold Last Quarter
Proj. Earnings Growth
Decreasing
From ($3.16) to ($3.34) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

372nd out of 970 stocks

Pharmaceutical Preparations Industry

155th out of 445 stocks


ALXO stock logo

About ALX Oncology (NASDAQ:ALXO) Stock

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. Its lead product candidate is evorpacept, a CD47 blocking therapeutic biologic in development as a combination therapy with other anti-cancer agents for treatment of various oncology indications, including myelodysplastic syndromes, acute myeloid leukemia, head and neck squamous cell carcinoma, gastric/gastroesophageal junction, and breast cancer. The company's pre-clinical program focuses on the development of ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer. ALX Oncology Holdings Inc. has collaboration agreements with Merck for a Phase 2 trial evaluating evorpacept in combination with pembrolizumab with and without chemotherapy in patients with head and neck cancer; Zymeworks on a Phase 1 trial for the treatment of HER2-expressing breast cancer and other solid tumors; Tallac Therapeutics, Inc. for the development of a potent immune activator targeted to myeloid cells in the tumor to promote innate and adaptive anti-cancer immune responses; and the Quantum Leap Healthcare Collaborative to sponsor and manage a Phase 1 trial to evaluate evorpacept in combination with fam-trastuzumab deruxtecan-nxki for the treatment of patients with unresectable or metastatic HER2-positive and HER2-low breast cancer. It also has license agreements with Board of Trustees of the Leland Stanford Junior University, Selexis SA, and Crystal Bioscience, Inc. The company was incorporated in 2015 and is headquartered in South San Francisco, California.

ALXO Price History

ALXO Stock News Headlines

Biden's Digital Dollar Nightmare
On July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted. You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again! Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!
Where ALX Oncology Holdings Stands With Analysts
ALX Oncology Realigns Executive Leadership Team
Biden's Digital Dollar Nightmare
On July 20th, 2023, the Federal Reserve launched FedNow, which could spark the fuse for a Digital Dollar. If a Digital Dollar happens, the government could: Monitor every transaction, keep track of your spending habits, and potentially control your individual choices… Which MAY steal your freedoms in one way or another. And if you don’t plan for this now... Your retirement savings could be at risk of being frozen, hacked, or deleted. You’ll want to act fast... Because with Biden’s long history of voting against Americans... Who knows how much longer until Biden strikes again! Get your hands on this FREE Wealth Protection Kit today and learn how you could shield your savings and investments before it’s too late!
4 Analysts Have This to Say About ALX Oncology Holdings
What 4 Analyst Ratings Have To Say About ALX Oncology Holdings
ALX Oncology GAAP EPS of -$0.74
ALXO ALX Oncology Holdings Inc.
See More Headlines
Receive ALXO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter.

ALXO Company Calendar

Last Earnings
8/10/2023
Today
10/01/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ALXO
Fax
N/A
Employees
72
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$21.00
High Stock Price Forecast
$34.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+337.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-123,480,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.18 million
Book Value
$6.46 per share

Miscellaneous

Free Float
20,453,000
Market Cap
$197.52 million
Optionable
Not Optionable
Beta
1.72
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Corey S. Goodman Ph.D. (Age 71)
    Exec. Chairman
    Comp: $84k
  • Mr. Jason W. LettmannMr. Jason W. Lettmann (Age 46)
    CEO & Director
    Comp: $60.5k
  • Dr. Jaume Pons Ph.D. (Age 57)
    Founder, Pres, Director & Chief Scientific Officer
    Comp: $856.29k
  • Mr. Peter S. Garcia M.B.A.Mr. Peter S. Garcia M.B.A. (Age 61)
    Chief Financial Officer
    Comp: $631.11k
  • Dr. Sophia Randolph M.D. (Age 55)
    Ph.D., Chief Medical Officer & Director
    Comp: $637.24k
  • Dr. Michael Chang Ph.D.
    VP of Operations
  • Ms. Shelly Pinto (Age 47)
    Sr. VP of Fin. & Chief Accounting Officer
  • Dr. Christopher Byrd J.D.
    Ph.D., Gen. Counsel
  • Ms. Jeanne Y. Jew (Age 59)
    Chief Bus. Officer
  • Dr. Athanasios Tsiatis M.D.
    Sr. VP of Clinical Devel.













ALXO Stock - Frequently Asked Questions

Should I buy or sell ALX Oncology stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ALX Oncology in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ALXO shares.
View ALXO analyst ratings
or view top-rated stocks.

What is ALX Oncology's stock price forecast for 2023?

6 equities research analysts have issued 1 year price targets for ALX Oncology's stock. Their ALXO share price forecasts range from $8.00 to $34.00. On average, they predict the company's share price to reach $21.00 in the next twelve months. This suggests a possible upside of 337.5% from the stock's current price.
View analysts price targets for ALXO
or view top-rated stocks among Wall Street analysts.

How have ALXO shares performed in 2023?

ALX Oncology's stock was trading at $11.27 at the start of the year. Since then, ALXO shares have decreased by 57.4% and is now trading at $4.80.
View the best growth stocks for 2023 here
.

When is ALX Oncology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our ALXO earnings forecast
.

How were ALX Oncology's earnings last quarter?

ALX Oncology Holdings Inc. (NASDAQ:ALXO) issued its earnings results on Thursday, August, 10th. The company reported ($0.84) earnings per share for the quarter, topping the consensus estimate of ($0.85) by $0.01.

What other stocks do shareholders of ALX Oncology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALX Oncology investors own include Cronos Group (CRON), Deere & Company (DE), GrowGeneration (GRWG), Innovative Industrial Properties (IIPR), Immunomedics (IMMU), Teck Resources (TECK), Abbott Laboratories (ABT), Ability (ABIL), AbbVie (ABBV) and

When did ALX Oncology IPO?

(ALXO) raised $128 million in an IPO on Friday, July 17th 2020. The company issued 8,000,000 shares at a price of $15.00-$17.00 per share. Jefferies, Credit Suisse, Piper Sandler and Cantor served as the underwriters for the IPO and LifeSci Capital was co-manager.

What is ALX Oncology's stock symbol?

ALX Oncology trades on the NASDAQ under the ticker symbol "ALXO."

How do I buy shares of ALX Oncology?

Shares of ALXO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ALX Oncology's stock price today?

One share of ALXO stock can currently be purchased for approximately $4.80.

How much money does ALX Oncology make?

ALX Oncology (NASDAQ:ALXO) has a market capitalization of $197.52 million and generates $1.18 million in revenue each year. The company earns $-123,480,000.00 in net income (profit) each year or ($3.20) on an earnings per share basis.

How can I contact ALX Oncology?

ALX Oncology's mailing address is 866 MALCOLM ROAD SUITE 100, BURLINGAME CA, 94010. The official website for the company is www.alxoncology.com. The company can be reached via phone at 650-466-7125 or via email at peter@alxoncology.com.

This page (NASDAQ:ALXO) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -